Tofacitinib Impurity 271
- CAS3100114-23-3
- CatalogueRS-T041074
- FormulaC13H18N6O
- MW274.32
On this page
Product identification
| Product name | Tofacitinib Impurity 271 |
|---|---|
| Catalogue No. | RS-T041074 |
| CAS No. | 3100114-23-3 |
| Molecular formula | C13H18N6O |
| Molecular weight | 274.32 |
| Availability | In stock— dispatched in about 1–2 weeks |
| Standard type | Nitrosamine Standards |
| Drug substance | Tofacitinib |
| Also known as | Tofacitinib Citrate Impurity 291 (N-Nitroso Tofacitinib Citrate Impurity 2) |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-T041074 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Tofacitinib
- Nitrosamine Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-T041074
- Request a quotation for RS-T041074
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Tofacitinib
All 145 further standards are listed here — every link is in the page, not loaded later.
-
Tofacitinib
IN STOCKRS-U046260 -
Tofacitinib Impurity C(Citrate)
IN STOCKRS-T041030 -
Tofacitinib Impurity D
IN STOCKRS-T041009 -
Tofacitinib Impurity E
IN STOCKRS-T041018 -
Tofacitinib Impurity G
IN STOCKRS-T041019 -
Tofacitinib Impurity H
IN STOCKRS-T041062 -
Tofacitinib Impurity L
IN STOCKRS-T041037 -
Tofacitinib Impurity M
IN STOCKRS-T041036 -
Tofacitinib Impurity M (1812890-23-5)
IN STOCKRS-T041047 -
Tofacitinib Impurity M Dihydrochloride
IN STOCKRS-T041089 -
Tofacitinib Impurity N
IN STOCKRS-T041025 -
Tofacitinib Impurity N(Citrate)
IN STOCKRS-T041046 -
Tofacitinib Impurity P
IN STOCKRS-T041058 -
Tofacitinib Impurity Q
IN STOCKRS-T041033 -
Tofacitinib Impurity Q (1675248-19-7)
IN STOCKRS-T041027 -
Tofacitinib Impurity R
CUSTOM SYNTHESISRS-T041038 -
Tofacitinib Impurity Y
CUSTOM SYNTHESISRS-T041054 -
(3R,4S)-Tofacitinib
IN STOCKRS-T041004 -
(3S,4R) Tofacitinib Citrate
BACK ORDERRS-T041029 -
(3S,4R)-Tofacitinib
IN STOCKRS-T041006 -
(3S,4S)-3-((1H-indol-4-yl)(methyl)amino)-4-methylpiperidin-1-ol
IN STOCKRS-T041351 -
(3S,4S)-Tofacitinib
IN STOCKRS-T041005 -
1,3-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)propane-1,3-dione
CUSTOM SYNTHESISRS-T041069 -
1-Benzyl-4-methylpiperidin-3-amine Dihydrochloride, Mixture of diastereomers
IN STOCKRS-Z401ERF -
5,7-dihydro-6H-pyrrolo [2,3-d] pyrimidin-6-one Impurity
CUSTOM SYNTHESISRS-T041078 -
6-amino-5-(2,2-diethoxyethyl)-2-mercaptopyrimidin-4-ol
IN STOCKRS-T041331 -
6-amino-5-(2,2-diethoxyethyl)pyrimidin-4-ol
IN STOCKRS-T041330 -
6-aminopyrimidin-4-ol
IN STOCKRS-T041329 -
N,4-Dimethyl-1-benzyl-3-piperidinamine D3
CUSTOM SYNTHESISRS-Z400PHL -
N,4-dimethylpiperidin-3-amine
IN STOCKRS-Z401DSI -
N4-Methyl Piperidinyl-4,6-pyrimidinediamine
CUSTOM SYNTHESISRS-Z401CSV -
sodium 6-amino-2-mercaptopyrimidin-4-olate
CUSTOM SYNTHESISRS-T041328 -
Tofacitinib (923036-28-6)
IN STOCKRS-T041197 -
Tofacitinib Citrate Mixure of Diastereomers
IN STOCKRS-T041092 -
Tofacitinib Diastereomer-1 and 2
IN STOCKRS-T041093 -
Tofacitinib Formyl Impurity
IN STOCKRS-T041055 -
Tofacitinib Impurity DT
IN STOCKRS-T041012 -
Tofacitinib Impurity FD+DX
IN STOCKRS-I009095 -
Tofacitinib Impurity N76
IN STOCKRS-T041094 -
Tofacitinib Impurity TBA
IN STOCKRS-T041024 -
Tofacitinib Related Substance 1
IN STOCKRS-T041090 -
Tofacitinib-D3 Citrate
BACK ORDERRS-Z401GQB -
Tofacitinib Related Compound 2 Hydrochloride
IN STOCKRS-T041088 -
Tofacitinib Impurity 8
IN STOCKRS-T095002 -
Tofacitinib Impurity 10
IN STOCKRS-T041007 -
Tofacitinib Impurity 11
CUSTOM SYNTHESISRS-T041042 -
Tofacitinib Impurity 13
IN STOCKRS-T041011 -
Tofacitinib Impurity 21
IN STOCKRS-T041065 -
Tofacitinib Related Compound 26 HCl
IN STOCKRS-T041040 -
Tofacitinib Impurity 35
BACK ORDERRS-I001ASU -
Tofacitinib Impurity 38
BACK ORDERRS-T041087 -
Tofacitinib Related Compound 38
CUSTOM SYNTHESISRS-T041076 -
Tofacitinib Impurity 45
CUSTOM SYNTHESISRS-T041085 -
Tofacitinib Impurity 66
BACK ORDERRS-Z401IVN -
Tofacitinib Impurity 89
CUSTOM SYNTHESISRS-U096674 -
Tofacitinib Impurity 91 (16372-08-0)
IN STOCKRS-T041194 -
Tofacitinib Impurity 92
CUSTOM SYNTHESISRS-I001BR3 -
Tofacitinib Impurity 93
IN STOCKRS-T041053 -
Tofacitinib Impurity 96
IN STOCKRS-T041050 -
Tofacitinib Impurity 97 (1638499-35-0)
CUSTOM SYNTHESISRS-T041195 -
Tofacitinib Impurity 98
IN STOCKRS-T041068 -
Tofacitinib Impurity 104
BACK ORDERRS-T041060 -
Tofacitinib Impurity 109
CUSTOM SYNTHESISRS-T041031 -
Tofacitinib Impurity 110
BACK ORDERRS-T041067 -
Tofacitinib Impurity 123
IN STOCKRS-T041008 -
Tofacitinib Impurity 125 HCl
IN STOCKRS-T041198 -
Tofacitinib Impurity 128 HCl
IN STOCKRS-Z400MMC -
Tofacitinib Impurity 133(Dihydrochloride)
IN STOCKRS-T041048 -
Tofacitinib Impurity 134
BACK ORDERRS-T095001 -
Tofacitinib Impurity 137
IN STOCKRS-T041021 -
Tofacitinib Impurity 138
IN STOCKRS-T041013 -
Tofacitinib Impurity 140
CUSTOM SYNTHESISRS-T041017 -
Tofacitinib Impurity 140 (Bromide)
IN STOCKRS-T041016 -
Tofacitinib Impurity 144
IN STOCKRS-Z401EWP -
Tofacitinib Impurity 146
IN STOCKRS-T041079 -
Tofacitinib Impurity 147
IN STOCKRS-T041082 -
Tofacitinib Impurity 148
BACK ORDERRS-I001AU7 -
Tofacitinib Impurity 149
CUSTOM SYNTHESISRS-T041032 -
Tofacitinib Impurity 153
IN STOCKRS-T041022 -
Tofacitinib Impurity 155(Hydrochloride)
IN STOCKRS-T041043 -
Tofacitinib Impurity 163
CUSTOM SYNTHESISRS-I001B7X -
Tofacitinib Impurity 176
CUSTOM SYNTHESISRS-I001AJY -
Tofacitinib Impurity 180
IN STOCKRS-I001AWJ -
Tofacitinib impurity 195
IN STOCKRS-I001830 -
Tofacitinib Impurity 201
IN STOCKRS-I001A5S -
Tofacitinib Impurity 203
IN STOCKRS-I001BLY -
Tofacitinib Impurity 214
IN STOCKRS-I001A1X -
Tofacitinib Impurity 217
IN STOCKRS-I001BO3 -
Tofacitinib Impurity 218
IN STOCKRS-I001AVM -
Tofacitinib Impurity 221
CUSTOM SYNTHESISRS-I001A29 -
Tofacitinib Impurity 232
IN STOCKRS-I001AJ9 -
Tofacitinib Impurity 242
IN STOCKRS-T041186 -
Tofacitinib Impurity 248
IN STOCKRS-I001715 -
Tofacitinib Impurity 250
CUSTOM SYNTHESISRS-T041095 -
Tofacitinib Impurity 251
CUSTOM SYNTHESISRS-I001877 -
Tofacitinib Impurity 264
IN STOCKRS-T041081 -
Tofacitinib Impurity 285
BACK ORDERRS-T041201 -
Tofacitinib Impurity 303
IN STOCKRS-T041203 -
Tofacitinib Impurity 312
IN STOCKRS-T041204 -
Tofacitinib Impurity 313
IN STOCKRS-T041187 -
Tofacitinib Impurity 317
IN STOCKRS-T041034 -
Tofacitinib Impurity 318
IN STOCKRS-T041035 -
Tofacitinib Impurity 320
IN STOCKRS-T041052 -
Tofacitinib Impurity 321
IN STOCKRS-T041071 -
Tofacitinib Impurity 322
IN STOCKRS-T041080 -
Tofacitinib Impurity 323
IN STOCKRS-T041189 -
Tofacitinib Impurity 324
BACK ORDERRS-T041190 -
Tofacitinib Impurity 325
BACK ORDERRS-T041191 -
Tofacitinib Impurity 326
BACK ORDERRS-T041193 -
Tofacitinib Impurity 330
IN STOCKRS-T095003 -
Tofacitinib Impurity 331
IN STOCKRS-T041199 -
Tofacitinib Impurity 332
IN STOCKRS-T041200 -
Tofacitinib Impurity 380
CUSTOM SYNTHESISRS-T041002 -
Tofacitinib Impurity 381
IN STOCKRS-T041003 -
Tofacitinib Impurity 382
IN STOCKRS-T041010 -
Tofacitinib Impurity 384
IN STOCKRS-T041020 -
Tofacitinib Impurity 385
IN STOCKRS-T041026 -
Tofacitinib Impurity 387
CUSTOM SYNTHESISRS-T041045 -
Tofacitinib Impurity 388
IN STOCKRS-T041049 -
Tofacitinib Impurity 389
BACK ORDERRS-T041051 -
Tofacitinib Impurity 390
IN STOCKRS-T041059 -
Tofacitinib Impurity 391
IN STOCKRS-T041061 -
Tofacitinib Impurity 392
CUSTOM SYNTHESISRS-T041063 -
Tofacitinib Impurity 394
BACK ORDERRS-T041070 -
Tofacitinib Impurity 395
IN STOCKRS-T041072 -
Tofacitinib Impurity 396
IN STOCKRS-T041073 -
Tofacitinib Impurity 397
CUSTOM SYNTHESISRS-T041075 -
Tofacitinib Impurity 398
IN STOCKRS-T041077 -
Tofacitinib Impurity 399
IN STOCKRS-T041083 -
Tofacitinib Impurity 400
IN STOCKRS-T041084 -
Tofacitinib Impurity 401
IN STOCKRS-T041086 -
Tofacitinib Impurity 402
IN STOCKRS-T041091 -
Tofacitinib Impurity 403
IN STOCKRS-T041096 -
Tofacitinib Impurity 423
IN STOCKRS-T041192 -
Tofacitinib Impurity 424
CUSTOM SYNTHESISRS-T041196 -
Tofacitinib Impurity 425
IN STOCKRS-T041202 -
Tofacitinib Impurity 456
IN STOCKRS-T041188
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.
















![Chemical structure of (3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-ol](/structures/w4/GZVGGNOCKBKBJH-KOLCDFICSA-N.webp?v=7)





![Chemical structure of 1,3-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)propane-1,3-dione](/structures/w4/CFVCYPAWDKDZTI-VKGYTVAMSA-N.webp?v=7)

![Chemical structure of 2-chloro-1-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone](/structures/w4/ASZSULBJLPUOKW-PWSUYJOCSA-N.webp?v=7)
![Chemical structure of 3-((3R,4R)-3-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile](/structures/w4/RINVSZVUBKMZHU-PWSUYJOCSA-N.webp?v=7)
![Chemical structure of 3-((3R,4R)-4-methyl-3-(methyl(6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](/structures/w4/FIQMDRYZOUHVEZ-PWSUYJOCSA-N.webp?v=7)
![Chemical structure of 3-((3R,4R)-4-methyl-3-(methyl(7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](/structures/w4/WZSHBRMUAGEXTG-XLIONFOSSA-N.webp?v=7)
![Chemical structure of 5,7-dihydro-6H-pyrrolo [2,3-d] pyrimidin-6-one Impurity](/structures/w4/NCIZQRMMYUHTDP-UHFFFAOYSA-N.webp?v=7)



![Chemical structure of Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate](/structures/w4/IQFJFTIXSPNYQX-ZBFHGGJFSA-N.webp?v=7)
![Chemical structure of ethyl 4-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-4-oxobutanoate](/structures/w4/ASXCOFXVKSZWRV-HIFRSBDPSA-N.webp?v=7)


![Chemical structure of N-methyl-N-((3S,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/structures/w4/XRIARWQZLGCQDM-MWLCHTKSSA-N.webp?v=7)































































































